Bay Street News, November 9th, 2018

Enoblituzumab + pembrolizumab combination study data reported: ORRs in anti-PD-1/PD-L1 naïve SCCHN and NSCLC cohorts benchmarked favorably vs. approved anti-PD-1 […]

In a release issued under the same headline earlier today by GNC Holdings, Inc. (NYSE: GNC), please note that in […]

COS COB, Conn., Nov. 09, 2018 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (“CSS Entertainment”) (Nasdaq: CSSE), […]

TORONTO, Nov. 09, 2018 (GLOBE NEWSWIRE) — (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) […]

For Immediate Release – not for distribution to US news wire services or for US dissemination. VANCOUVER, British Columbia, Nov. […]

Reports Third Quarter Revenue Growth of 14.0% ALLENTOWN, Pa., Nov. 09, 2018 (GLOBE NEWSWIRE) — JetPay® Corporation (“JetPay” or the […]

SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third […]

FutureFuel Third Quarter Net Income of $9.4 Million Reports Net Income of $9.4 Million or $0.22 per Diluted Share, and […]

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) — The Asia Pacific Fund, Inc. (NYSE:APB) announced today that the liquidation and […]

ALLEN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended […]